(Total Views: 690)
Posted On: 11/23/2020 6:01:07 AM
Post# of 154474
New PR....
CytoDyn Reaches Enrollment Target of 293 Patients for 2nd DSMC Interim Analysis of Phase 3 COVID-19 Trial and Expects to Enroll the Remaining 97 Patients in the Next Few Weeks to Complete the Trial This Year
https://www.cytodyn.com/newsroom/press-releas...ts-for-2nd
CytoDyn Reaches Enrollment Target of 293 Patients for 2nd DSMC Interim Analysis of Phase 3 COVID-19 Trial and Expects to Enroll the Remaining 97 Patients in the Next Few Weeks to Complete the Trial This Year
https://www.cytodyn.com/newsroom/press-releas...ts-for-2nd
(2)
(0)
